Pregnancy outcomes for women taking medications for rheumatic disease offer reassuring information. Also, details about forthcoming labeling changes for medications used during pregnancy, including biologics.
For treating rheumatoid arthritis not responsive to methotrexate, DMARD combinations beat monotherapy but at greater risk, a summary of recent evidence observes. In another, reviewers disagree about triple therapy.
(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.